Posted on April 14, 2021 by William Brauner
We recently participated in a conference call with FDA representatives in attendance. During this meeting it was made clear that the FDA would be increasing both remote, and on-site inspections, and reviews of compliance with the FSVP program. Based on their recent experience with FSVP enforcement, the FDA anticipates it will be issuing more warning …
READ MORE